BLOCKADE OF TOLERANCE TO MORPHINE BUT NOT TO KAPPA-OPIOIDS BY A NITRIC-OXIDE SYNTHASE INHIBITOR
BLOCKADE OF TOLERANCE TO MORPHINE BUT NOT TO KAPPA-OPIOIDS BY A NITRIC-OXIDE SYNTHASE INHIBITOR
复制标题
DOI:
10.1073/pnas.90.11.5162
复制
发表时间:
1993-06-01
影响因子:
11.1
通讯作者:
PASTERNAK, GW
中科院分区:
文献类型:
--
作者:
KOLESNIKOV, YA;PICK, CG;PASTERNAK, GW
The nitric oxide synthase inhibitor N(G)-nitro-L-arginine (NO2Arg) blocks morphine tolerance in mice. After implantation of morphine pellets the analgesic response decreases from 100% on the first day to 0% on the third. Coadministration of NO2Arg along with the pellets markedly retards the development of tolerance; 60% of mice are analgesic after 3 days, and 50% of mice are analgesic after 5 days. In a daily injection paradigm the analgesic response to morphine is reduced from 60% to 0% by 5 days. Concomitant administration of morphine along with NO2Arg at doses of 2 mg/kg per day prevents tolerance for 4 weeks. A single NO2Arg dose retards morphine tolerance for several days, and dosing every 4 days is almost as effective as daily NO2Arg. NO2Arg slowly reverses preexisting tolerance over 5 days despite the continued administration of morphine along with NO2Arg. NO2Arg also reduces dependence and reverses previously established dependence. NO2Arg does not prevent tolerance to analgesia mediated by the kappa1 agonist trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolindinyl)cyclohexyl]-benzene-acetamide (U50,488H) or the kappa3 agent naloxone benzoylhydrazone, indicating a selective action of NO in the mechanisms of mu tolerance and dependence.